MedTrace Logo

Adrenal Tumors - Pathogenesis and Therapy

NCT00669266 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-05-07

No results posted yet for this study

Summary

The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.

Conditions

  • Adrenal Tumors
  • Adrenocortical Carcinoma
  • Cushing Syndrome
  • Conn Syndrome
  • Pheochromocytoma

Sponsors & Collaborators

  • Deutsche Krebshilfe e.V., Bonn (Germany)

    collaborator OTHER

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • University of Wuerzburg

    lead OTHER

Principal Investigators

  • Martin Fassnacht, MD · U of Wuerzburg

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2030-12-31
Completion
2032-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00669266 on ClinicalTrials.gov